
DelistingNov 18, 2026, 05:04 PM
Medirom Receives Nasdaq Delisting Notice, Files Annual Report, Seeks Hearing
AI Summary
Medirom Healthcare Technologies Inc. received a delisting notice from Nasdaq due to its failure to file its Annual Report on Form 20-F for the year ended December 31, 2025. The company has filed the Annual Report and requested a hearing with Nasdaq to appeal the delisting determination and seek a stay of suspension pending the hearing. Separately, Medirom is also non-compliant with the minimum bid price requirement, with a deadline of April 5, 2027, to regain compliance.
Key Highlights
- Medirom received a Nasdaq delisting notice for not filing its 2025 Annual Report on Form 20-F.
- The company filed its 2025 Annual Report on November 18, 2026.
- Medirom requested a hearing with Nasdaq to appeal the delisting determination.
- A hearing request automatically stays trading suspension for 15 days; Medirom requested an extended stay.
- The company also faces a separate minimum bid price deficiency with a compliance deadline of April 5, 2027.
Price Impact
More from MRM
Regulatory1d ago, 6:45 PM
MEDIROM Regains Nasdaq Periodic Filing Compliance; Bid Price Deficiency Remains
Regulatory3d ago, 4:46 PM
Medirom Healthcare Receives Nasdaq Delisting Notice; Appeals Determination
RegulatoryOct 13, 4:31 PM
Medirom Healthcare Technologies Receives Nasdaq Bid Price Non-Compliance Notice